FDA Approved: CLARINEX — Supplemental Application (Organon LLC)

View source ↗

Summary

FDA has approved a supplemental application for CLARINEX (desloratadine) submitted by Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Idiopathic Urticaria

Drugs mentioned

• Clarinex (desloratadine)

Snippet

SUPPL AP for CLARINEX (DESLORATADINE)